Early cessation of antibiotics possible in chemotherapy-treated AML, MDS patients

External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Jun 17 / Springer Healthcare

Early cessation of antibiotics possible in chemotherapy-treated AML, MDS patients

University Hospitals Leuven, Belgium

Haematology EHA-2020

Description

Alexander Schauwvlieghe discusses their retrospective cohort study evaluating two approaches for antibiotic therapy in patients with acute myeloid leukaemia or myelodysplastic syndromes who develop febrile neutropenia during induction chemotherapy.

Follow us here

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.